A major phase III clinical trial has found that DCVax®-L, a dendritic cell brain tumor vaccine, can prolong the lives of patients diagnosed with new or recurrent glioblastomas.
Breast cancer is the second most common type of cancer to metastasize to the brain. Thankfully, targeted therapies are driving major advances in treatment and improving life expectancy from a number of months to a number of years. Oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center Bonni Lee Guerin, MD, shares the latest.
Investigational clinical trials are at the heart of innovation in brain tumor treatment. At the Gerald J. Glasser Brain Tumor Center, we have a robust clinical trial research infrastructure in place.
A Phase 2/3 clinical trial called Toca 5 - investigating a retroviral gene therapy treatment in patients with recurrent brain cancer - is actively enrolling at Altair Health.
Dr. Paul Saphier, a board-certified neurosurgeon and stroke specialist at Altair Health in Morristown, NJ, is helping spearhead an effort to advance what the medical community considers the best medical treatment for hemorrhagic strokes … and improve outcomes for patients.
Board-certified neurosurgeon participates in FDA/IDE study examining use of TOPS™ System